* Newstin.co.uk is for sale! * After achieving our strategic milestone, we are offering for sale: Newstin.co.uk and all 14 related domains featuring 1 million unique visitors per month + continuously updated news database of 37 million articles in 12 world languages from 166,000 global and weighted sources + 2.1 billion metadata * To seize this unique chance, contact invest@newstin.com. * Newstin.co.uk is for sale! *

Myriad Genetics Sells Flurizan Licensing Rights (at TheStreet.com)
yahoo.com
22-May-2008 24 related
        

Myriad Genetics MYGN said early Thursday that it sold rights outside the U.S. rights to its late-stage Alzheimer's drug Flurizan. The biotech company struck a deal worth as much as $350 million with Lundbeck A/S. The Danish company will pay Myriad $100 million upfront and up to $250 million in... [read full story]                    

Add Comment
There are also 24 related articles
View all news articles about*:
Alzheimer's Behavior Disease Genetics Health Mental Myriad
*Newstin tag cloud displays all featured persons, associated organisations, related topics, regions and companies

View other selected articles:

                   

Drug firms to invest in AIDS research: U.N

pharmiweb.co.uk
35 mins ago 12 related
        

By Louis Charbonneau, Reuters Saturday, October 11, 2008 10:59 am UNITED NATIONS –– U.N. Secretary-General Ban Ki-Moon said on Thursday that major pharmac eutical firms promised to invest more on researching treatments for the...

add comment